{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T18:37:50Z","timestamp":1778265470286,"version":"3.51.4"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,1,2]],"date-time":"2024-01-02T00:00:00Z","timestamp":1704153600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,1,2]],"date-time":"2024-01-02T00:00:00Z","timestamp":1704153600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004484","name":"Tehran University of Medical Sciences and Health Services","doi-asserted-by":"publisher","award":["54103"],"award-info":[{"award-number":["54103"]}],"id":[{"id":"10.13039\/501100004484","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Hepatic osteodystrophy, a prevalent manifestation of metabolic bone disease, can arise in the context of chronic liver disease. The THBS1-eNOS-NO signaling pathway plays a pivotal role in the maturation of osteoclast precursors. This study aimed to investigate the impact of Naltrexone (NTX) on bone loss by examining the THBS1-eNOS-NO signaling pathways in bile duct ligated (BDL) rats. Male Wistar rats were randomly divided into five groups (n\u2009=\u200910 per group): control, sham-operated\u2009+\u2009normal saline, BDL\u2009+\u2009normal saline, sham-operated\u2009+\u2009NTX (10 mg\/kg), and BDL\u2009+\u2009NTX. Parameters related to liver injury were measured at the study's conclusion, and Masson-trichrome staining was employed to evaluate collagen deposition in liver tissue. Bone THBS-1 and endothelial nitric oxide synthase (eNOS) expression levels were measured using real-time PCR, while the level of bone nitric oxide (NO) was assessed through a colorimetric assay. NTX treatment significantly attenuated the BDL-induced increase in circulating levels of liver enzymes and bilirubin. THBS-1 expression levels, elevated after BDL, were significantly suppressed following NTX administration in the BDL\u2009+\u2009NTX group. Despite no alterations in eNOS expression between groups, the bone NO level, significantly decreased in the BDL group, was significantly reduced by NTX in the BDL\u2009+\u2009NTX group. This study partly provides insights into the possible molecular mechanisms in BDL-induced osteoporosis and highlights the modulating effect of NTX on these pathways. Further research is needed to establish the impact of NTX on histomorphometric indexes.<\/jats:p>","DOI":"10.1038\/s41598-023-50547-w","type":"journal-article","created":{"date-parts":[[2024,1,2]],"date-time":"2024-01-02T10:02:14Z","timestamp":1704189734000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Exploring the impact of naltrexone on the THBS1\/eNOS\/NO pathway in osteoporotic bile duct-ligated rats"],"prefix":"10.1038","volume":"14","author":[{"given":"Seyed Reza","family":"Hosseini-Fard","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shahroo","family":"Etemad-Moghadam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mojgan","family":"Alaeddini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmad Reza","family":"Dehpour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Solaleh","family":"Emamgholipour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abolfazl","family":"Golestani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,1,2]]},"reference":[{"issue":"2","key":"50547_CR1","first-page":"82","volume":"31","author":"V Goel","year":"2010","unstructured":"Goel, V. & Kar, P. Hepatic osteodystrophy. Trop. Gastroenterol. 31(2), 82\u201386 (2010).","journal-title":"Trop. Gastroenterol."},{"issue":"12","key":"50547_CR2","doi-asserted-by":"publisher","first-page":"300","DOI":"10.4254\/wjh.v3.i12.300","volume":"3","author":"G L\u00f3pez-Larramona","year":"2011","unstructured":"L\u00f3pez-Larramona, G., Lucendo, A. J., Gonz\u00e1lez-Castillo, S. & Tenias, J. M. Hepatic osteodystrophy: An important matter for consideration in chronic liver disease. World J. Hepatol. 3(12), 300 (2011).","journal-title":"World J. Hepatol."},{"issue":"10","key":"50547_CR3","doi-asserted-by":"publisher","first-page":"2555","DOI":"10.3390\/ijms20102555","volume":"20","author":"S Ehnert","year":"2019","unstructured":"Ehnert, S. et al. Hepatic osteodystrophy\u2014Molecular mechanisms proposed to favor its development. Int. J. Mol. Sci. 20(10), 2555 (2019).","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"50547_CR4","first-page":"596","volume":"33","author":"\u0399 Mani","year":"2016","unstructured":"Mani, \u0399 & Dourakis, S. Hepatic osteodystrophy: Current views. Arch. Hellenic Med. 33(5), 596\u2013609 (2016).","journal-title":"Arch. Hellenic Med."},{"issue":"2","key":"50547_CR5","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.bone.2013.03.012","volume":"55","author":"K Hochrath","year":"2013","unstructured":"Hochrath, K. et al. Modeling hepatic osteodystrophy in Abcb4 deficient mice. Bone 55(2), 501\u2013511 (2013).","journal-title":"Bone"},{"key":"50547_CR6","doi-asserted-by":"publisher","first-page":"2194","DOI":"10.1007\/s11999-010-1694-9","volume":"469","author":"A Unnanuntana","year":"2011","unstructured":"Unnanuntana, A., Rebolledo, B. J., Michael Khair, M., DiCarlo, E. F. & Lane, J. M. Diseases affecting bone quality: Beyond osteoporosis. Clin. Orthopaed. Relat. Res. 469, 2194\u20132206 (2011).","journal-title":"Clin. Orthopaed. Relat. Res."},{"issue":"1","key":"50547_CR7","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1053\/jhep.2001.20533","volume":"33","author":"S Rouillard","year":"2001","unstructured":"Rouillard, S. & Lane, N. E. Hepatic osteodystrophy. Hepatology 33(1), 301\u2013307 (2001).","journal-title":"Hepatology"},{"key":"50547_CR8","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/s002239900622","volume":"64","author":"O Crosbie","year":"1999","unstructured":"Crosbie, O., Freaney, R., McKenna, M. & Hegarty, J. Bone density, vitamin D status, and disordered bone remodeling in end-stage chronic liver disease. Calcif. Tissue Int. 64, 295\u2013300 (1999).","journal-title":"Calcif. Tissue Int."},{"issue":"10","key":"50547_CR9","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1002\/(SICI)1521-1878(199810)20:10<837::AID-BIES9>3.0.CO;2-D","volume":"20","author":"HC Blair","year":"1998","unstructured":"Blair, H. C. How the osteoclast degrades bone. Bioessays 20(10), 837\u2013846 (1998).","journal-title":"Bioessays"},{"issue":"3","key":"50547_CR10","first-page":"512","volume":"56","author":"E-C Barbu","year":"2017","unstructured":"Barbu, E.-C. et al. Hepatic osteodystrophy: A global (Re) view of the problem. Acta Clinica Croatica 56(3), 512\u2013525 (2017).","journal-title":"Acta Clinica Croatica"},{"issue":"11","key":"50547_CR11","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.1002\/jbmr.5650101109","volume":"10","author":"RA Dodds","year":"1995","unstructured":"Dodds, R. A. et al. Human osteoclasts, not osteoblasts, deposit osteopontin onto resorption surfaces: An in vitro and ex vivo study of remodeling bone. J. Bone Miner. Res. 10(11), 1666\u20131680 (1995).","journal-title":"J. Bone Miner. Res."},{"issue":"1","key":"50547_CR12","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1111\/j.0105-2896.2005.00327.x","volume":"208","author":"S Tanaka","year":"2005","unstructured":"Tanaka, S., Nakamura, K., Takahasi, N. & Suda, T. Role of RANKL in physiological and pathological bone resorption and therapeutics targeting the RANKL\u2013RANK signaling system. Immunol. Rev. 208(1), 30\u201349 (2005).","journal-title":"Immunol. Rev."},{"issue":"4","key":"50547_CR13","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1359\/jbmr.2003.18.4.599","volume":"18","author":"M Zaidi","year":"2003","unstructured":"Zaidi, M., Blair, H. C., Moonga, B. S., Abe, E. & Huang, C. L. H. Osteoclastogenesis, bone resorption, and osteoclast-based therapeutics. J. Bone Miner. Res. 18(4), 599\u2013609 (2003).","journal-title":"J. Bone Miner. Res."},{"key":"50547_CR14","doi-asserted-by":"publisher","first-page":"4992","DOI":"10.2741\/3583","volume":"14","author":"R Weiskirchen","year":"2009","unstructured":"Weiskirchen, R. et al. BMP-7 as antagonist of organ fibrosis. Front. Biosci. 14, 4992\u20135012 (2009).","journal-title":"Front. Biosci."},{"key":"50547_CR15","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1007\/s00109-017-1526-4","volume":"95","author":"S Ehnert","year":"2017","unstructured":"Ehnert, S. et al. TGF-\u03b2 1 impairs mechanosensation of human osteoblasts via HDAC6-mediated shortening and distortion of primary cilia. J. Mol. Med. 95, 653\u2013663 (2017).","journal-title":"J. Mol. Med."},{"issue":"4","key":"50547_CR16","doi-asserted-by":"publisher","first-page":"41","DOI":"10.3390\/jfmk2040041","volume":"2","author":"S Ehnert","year":"2017","unstructured":"Ehnert, S., Heuberger, E., Linnemann, C., Nussler, A. K. & Pscherer, S. TGF-\u03b21-Dependent downregulation of HDAC9 inhibits maturation of human osteoblasts. J. Funct. Morphol. Kinesiol. 2(4), 41 (2017).","journal-title":"J. Funct. Morphol. Kinesiol."},{"issue":"1","key":"50547_CR17","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1080\/07435800.2017.1373662","volume":"43","author":"N Wang","year":"2018","unstructured":"Wang, N. et al. Role of sclerostin and dkk1 in bone remodeling in type 2 diabetic patients. Endocrine Res. 43(1), 29\u201338 (2018).","journal-title":"Endocrine Res."},{"issue":"1","key":"50547_CR18","doi-asserted-by":"publisher","first-page":"8475","DOI":"10.1038\/s41598-018-26820-8","volume":"8","author":"S Biswas","year":"2018","unstructured":"Biswas, S. et al. BMPRIA is required for osteogenic differentiation and RANKL expression in adult bone marrow mesenchymal stromal cells. Sci. Rep. 8(1), 8475 (2018).","journal-title":"Sci. Rep."},{"key":"50547_CR19","doi-asserted-by":"crossref","unstructured":"Thrombospondin-1, Free Radicals, and the Coronary Microcirculation: The Aging Conundrum. Antioxidants & Redox Signaling, 2017. 27(12): p. 785\u2013801.","DOI":"10.1089\/ars.2017.7292"},{"issue":"39","key":"50547_CR20","doi-asserted-by":"publisher","first-page":"15055","DOI":"10.1074\/jbc.RA117.000633","volume":"293","author":"SV Koduru","year":"2018","unstructured":"Koduru, S. V. et al. The contribution of cross-talk between the cell-surface proteins CD36 and CD47\u2013TSP-1 in osteoclast formation and function. J. Biol. Chem. 293(39), 15055\u201315069 (2018).","journal-title":"J. Biol. Chem."},{"issue":"11","key":"50547_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1096\/fj.02-0830fje","volume":"17","author":"K Jurk","year":"2003","unstructured":"Jurk, K. et al. Thrombospondin-1 mediates platelet adhesion at high shear via glycoprotein Ib (GPIb): An alternative\/backup mechanism to von Willebrand factor. FASEB J. 17(11), 1\u201318 (2003).","journal-title":"FASEB J."},{"issue":"4","key":"50547_CR22","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1083\/jcb.200407060","volume":"168","author":"SM Short","year":"2005","unstructured":"Short, S. M. et al. Inhibition of endothelial cell migration by thrombospondin-1 type-1 repeats is mediated by \u03b21 integrins. J. Cell Biol. 168(4), 643\u2013653 (2005).","journal-title":"J. Cell Biol."},{"issue":"3","key":"50547_CR23","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/j.cell.2013.12.039","volume":"156","author":"J-H Lee","year":"2014","unstructured":"Lee, J.-H. et al. Lung stem cell differentiation in mice directed by endothelial cells via a BMP4-NFATc1-thrombospondin-1 axis. Cell 156(3), 440\u2013455 (2014).","journal-title":"Cell"},{"issue":"18","key":"50547_CR24","doi-asserted-by":"publisher","first-page":"2116","DOI":"10.2174\/1381612826666200128091506","volume":"26","author":"P Wang","year":"2020","unstructured":"Wang, P. et al. Thrombospondin-1 as a potential therapeutic target: Multiple roles in cancers. Curr. Pharm. Design 26(18), 2116\u20132136 (2020).","journal-title":"Curr. Pharm. Design"},{"issue":"6","key":"50547_CR25","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1038\/sj.bjc.6605203","volume":"101","author":"SL Maloney","year":"2009","unstructured":"Maloney, S. L. et al. Induction of thrombospondin-1 partially mediates the anti-angiogenic activity of dexrazoxane. Br. J. Cancer 101(6), 957\u2013966 (2009).","journal-title":"Br. J. Cancer"},{"issue":"1","key":"50547_CR26","first-page":"18","volume":"9","author":"BA Kerr","year":"2021","unstructured":"Kerr, B. A. et al. Platelet TSP-1 controls prostate cancer-induced osteoclast differentiation and bone marrow-derived cell mobilization through TGF\u03b2-1. Am. J. Clin. Exp. Urol. 9(1), 18 (2021).","journal-title":"Am. J. Clin. Exp. Urol."},{"issue":"7","key":"50547_CR27","doi-asserted-by":"publisher","first-page":"662","DOI":"10.18632\/oncotarget.200","volume":"1","author":"G Taraboletti","year":"2010","unstructured":"Taraboletti, G., Rusnati, M., Ragona, L. & Colombo, G. Targeting tumor angiogenesis with TSP-1-based compounds: Rational design of antiangiogenic mimetics of endogenous inhibitors. Oncotarget 1(7), 662 (2010).","journal-title":"Oncotarget"},{"issue":"1\u20132","key":"50547_CR28","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/0014-2999(84)90374-1","volume":"104","author":"A Takemori","year":"1984","unstructured":"Takemori, A. & Portoghese, P. Comparative antagonism by naltrexone and naloxone of \u03bc, \u03ba, and \u03b4 agonists. Eur. J. Pharmacol. 104(1\u20132), 101\u2013104 (1984).","journal-title":"Eur. J. Pharmacol."},{"issue":"11","key":"50547_CR29","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.1111\/bph.14148","volume":"175","author":"JP Anand","year":"2018","unstructured":"Anand, J. P. et al. In vivo effects of \u03bc-opioid receptor agonist\/\u03b4-opioid receptor antagonist peptidomimetics following acute and repeated administration. Br. J. Pharmacol. 175(11), 2013\u20132027 (2018).","journal-title":"Br. J. Pharmacol."},{"issue":"11","key":"50547_CR30","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1136\/gut.2005.076778","volume":"55","author":"MR Ebrahimkhani","year":"2006","unstructured":"Ebrahimkhani, M. R. et al. Naltrexone, an opioid receptor antagonist, attenuates liver fibrosis in bile duct ligated rats. Gut 55(11), 1606\u20131616 (2006).","journal-title":"Gut"},{"key":"50547_CR31","doi-asserted-by":"publisher","first-page":"120576","DOI":"10.1016\/j.lfs.2022.120576","volume":"300","author":"SR Hosseini-Fard","year":"2022","unstructured":"Hosseini-Fard, S. R., Dehpour, A. R., Emamgholipour, S. & Golestani, A. Naltrexone protects against BDL-induced cirrhosis in Wistar rats by attenuating thrombospondin-1 and enhancing antioxidant defense system via Nrf-2. Life Sci. 300, 120576 (2022).","journal-title":"Life Sci."},{"issue":"2","key":"50547_CR32","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1111\/1440-1681.12695","volume":"44","author":"A Moslehi","year":"2017","unstructured":"Moslehi, A., Nabavizadeh, F., Zekri, A. & Amiri, F. Naltrexone changes the expression of lipid metabolism-related proteins in the endoplasmic reticulum stress induced hepatic steatosis in mice. Clin. Exp. Pharm. Physiol. 44(2), 207\u2013212 (2017).","journal-title":"Clin. Exp. Pharm. Physiol."},{"key":"50547_CR33","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.lfs.2019.03.069","volume":"224","author":"K Tanaka","year":"2019","unstructured":"Tanaka, K., Kondo, H., Hamamura, K. & Togari, A. Systemic administration of low-dose naltrexone increases bone mass due to blockade of opioid growth factor receptor signaling in mice osteoblasts. Life Sci. 224, 232\u2013240 (2019).","journal-title":"Life Sci."},{"key":"50547_CR34","doi-asserted-by":"publisher","first-page":"106056","DOI":"10.1016\/j.intimp.2019.106056","volume":"79","author":"N Xu","year":"2020","unstructured":"Xu, N. et al. Naltrexone (NTX) relieves inflammation in the collagen-induced- arthritis (CIA) rat models through regulating TLR4\/NF\u03baB signaling pathway. Int. Immunopharmacol. 79, 106056 (2020).","journal-title":"Int. Immunopharmacol."},{"issue":"3","key":"50547_CR35","doi-asserted-by":"publisher","first-page":"239","DOI":"10.4103\/1735-5362.228954","volume":"13","author":"AH Doustimotlagh","year":"2018","unstructured":"Doustimotlagh, A. H. et al. A study on OPG\/RANK\/RANKL axis in osteoporotic bile duct-ligated rats and the involvement of nitrergic and opioidergic systems. Res. Pharm. Sci. 13(3), 239 (2018).","journal-title":"Res. Pharm. Sci."},{"key":"50547_CR36","doi-asserted-by":"publisher","first-page":"116706","DOI":"10.1016\/j.lfs.2019.116706","volume":"233","author":"M Moradi","year":"2019","unstructured":"Moradi, M., Doustimotlagh, A. H., Dehpour, A. R., Rahimi, N. & Golestani, A. The influence of TRAIL, adiponectin and sclerostin alterations on bone loss in BDL-induced cirrhotic rats and the effect of opioid system blockade. Life Sci. 233, 116706 (2019).","journal-title":"Life Sci."},{"issue":"13","key":"50547_CR37","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.3748\/wjg.v16.i13.1639","volume":"16","author":"V Goral","year":"2010","unstructured":"Goral, V., Simsek, M. & Mete, N. Hepatic osteodystrophy and liver cirrhosis. World J. Gastroenterol. WJG 16(13), 1639 (2010).","journal-title":"World J. Gastroenterol. WJG"},{"issue":"6","key":"50547_CR38","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1111\/j.1440-1746.2007.04875.x","volume":"22","author":"E Dulundu","year":"2007","unstructured":"Dulundu, E. et al. Grape seed extract reduces oxidative stress and fibrosis in experimental biliary obstruction. J. Gastroenterol. Hepatol. 22(6), 885\u2013892 (2007).","journal-title":"J. Gastroenterol. Hepatol."},{"issue":"2","key":"50547_CR39","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.jep.2006.07.042","volume":"109","author":"T-Y Lee","year":"2007","unstructured":"Lee, T.-Y., Chang, H.-H., Chen, J.-H., Hsueh, M.-L. & Kuo, J.-J. Herb medicine Yin-Chen-Hao-Tang ameliorates hepatic fibrosis in bile duct ligation rats. J. Ethnopharmacol. 109(2), 318\u2013324 (2007).","journal-title":"J. Ethnopharmacol."},{"issue":"12","key":"50547_CR40","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.3390\/antiox9121279","volume":"9","author":"E Ramos-Tovar","year":"2020","unstructured":"Ramos-Tovar, E. & Muriel, P. Molecular mechanisms that link oxidative stress, inflammation, and fibrosis in the liver. Antioxidants 9(12), 1279 (2020).","journal-title":"Antioxidants"},{"issue":"7","key":"50547_CR41","first-page":"743","volume":"32","author":"AH Doustimotlagh","year":"2017","unstructured":"Doustimotlagh, A. H. et al. Nitrergic and opioidergic systems affect radiographic density and histomorphometric indices in bile-duct-ligated cirrhotic rats. Histol. Histopathol. 32(7), 743\u2013749 (2017).","journal-title":"Histol. Histopathol."},{"issue":"4","key":"50547_CR42","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1111\/j.1872-034X.2012.01075.x","volume":"43","author":"H Derakhshanian","year":"2013","unstructured":"Derakhshanian, H. et al. Quercetin improves bone strength in experimental biliary cirrhosis. Hepatol. Res. 43(4), 394\u2013400 (2013).","journal-title":"Hepatol. Res."},{"key":"50547_CR43","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1590\/S0100-879X2012007500143","volume":"45","author":"F Pereira","year":"2012","unstructured":"Pereira, F. et al. Pamidronate for the treatment of osteoporosis secondary to chronic cholestatic liver disease in Wistar rats. Braz. J. Med. Biol. Res. 45, 1255\u20131261 (2012).","journal-title":"Braz. J. Med. Biol. Res."},{"issue":"1","key":"50547_CR44","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1002\/jbmr.2308","volume":"30","author":"SR Amend","year":"2015","unstructured":"Amend, S. R. et al. Thrombospondin-1 regulates bone homeostasis through effects on bone matrix integrity and nitric oxide signaling in osteoclasts. J. Bone Miner. Res. 30(1), 106\u2013115 (2015).","journal-title":"J. Bone Miner. Res."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-50547-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-50547-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-50547-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,2]],"date-time":"2024-01-02T11:09:33Z","timestamp":1704193773000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-50547-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,2]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["50547"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-50547-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,2]]},"assertion":[{"value":"1 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 December 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"48"}}